GC GENELUX CORP Stock: price and directors' dealings · United States · SEC (Form 4)Track the GENELUX CORP stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €116.6m. The latest transaction was reported on 4 August 2026 (Cession). Among the most active insiders: Yu Yong. The full history is accessible without an account.
Analyst consensus: bullish or bearish? Analysts rate GENELUX CORP Strong Buy (bullish), based on 6 analysts. Average price target: US$17.50.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 August 2026
All Executives140 Thresholds0 Prospectus0 Other0
Declarations 140 total
▼ President and CEO · Executives · 4 Aug 2026
3,023 shares @ US$2.9459 0.0068% mcap 2.6% of flow Common Stock SEC:0001493152-26-036075:0
▼ Chief Scientific Officer · Executives · 4 Aug 2026
653 shares @ US$2.9434 0.0015% mcap 0.1% of flow Common Stock SEC:0001493152-26-036077:0
▼ Chief Technical Officer · Executives · 4 Aug 2026
653 shares @ US$2.9467 0.0015% mcap 1.6% of flow Common Stock SEC:0001493152-26-036076:0
◆ Director · Executives · 16 Jun 2026
28,409 shares Common Stock SEC:0001493152-26-029418:0
◆ Chief Technical Officer · Executives · 16 Jun 2026
174,841 shares Common Stock SEC:0001493152-26-029419:0
◆ Director · Executives · 16 Jun 2026
28,409 shares Common Stock SEC:0001493152-26-029413:0
◆ Chief Scientific Officer · Executives · 16 Jun 2026
119,318 shares Common Stock SEC:0001493152-26-029414:0
◆ Director · Executives · 16 Jun 2026
28,409 shares Common Stock SEC:0001493152-26-029415:0
◆ Director · Executives · 16 Jun 2026
28,409 shares Common Stock SEC:0001493152-26-029416:0
◆ President and CEO · Executives · 16 Jun 2026
730,601 shares Common Stock SEC:0001493152-26-029417:0
◆ General Counsel · Executives · 16 Jun 2026
233,957 shares Common Stock SEC:0001493152-26-029420:0
◆ Chief Financial Officer · Executives · 16 Jun 2026
278,906 shares Common Stock SEC:0001493152-26-029421:0
▼ Head of Regulatory · Executives · 3 Jun 2026
192 shares @ US$2.93 0.0004% mcap 1.6% of flow Common Stock SEC:0001493152-26-027348:0
▼ Chief Technical Officer · Executives · 24 Mar 2026
906 shares @ US$2.42 1.9% of flow Common Stock SEC:0001493152-26-012971:0
▼ SVP, Clinical Development · Executives · 24 Mar 2026
906 shares @ US$2.42 0.1% of flow Common Stock SEC:0001493152-26-012970:0
▼ President and CEO · Executives · 24 Mar 2026
3,582 shares @ US$2.42 3.0% of flow Common Stock SEC:0001493152-26-012969:0
▼ Head of Regulatory · Executives · 24 Mar 2026
345 shares @ US$2.42 2.4% of flow Common Stock SEC:0001493152-26-012972:0
▼ Director · Executives · 2 Mar 2026
10,000 shares @ US$2.8957 9.9% of flow Common Stock SEC:0001493152-26-008743:0
▼ President and CEO · Executives · 21 Aug 2025
12,673 shares @ US$3.3267 12.7% of flow Common Stock SEC:0001493152-25-027339:0
▼ SVP, Clinical Development · Executives · 21 Aug 2025
3,219 shares @ US$3.3574 0.4% of flow Common Stock SEC:0001493152-25-027338:0
▼ Chief Technical Officer · Executives · 21 Aug 2025
1,270 shares @ US$3.3267 3.5% of flow Common Stock SEC:0001493152-25-027337:0
▼ Head of Regulatory · Executives · 21 Aug 2025
1,244 shares @ US$3.3574 10.5% of flow Common Stock SEC:0001493152-25-026981:0
▼ Director · Executives · 1 Dec 2025
10,000 shares @ US$5.0008 19.3% of flow Common Stock SEC:0001493152-25-025811:0
◆ Head of Regulatory · Executives · 1 Sept 2025
10,000 shares 0Common Stock SEC:0001641172-25-026396:0
◆ Director · Executives · 27 Aug 2025
22,283 shares 0Common Stock SEC:0001641172-25-026006:0
25 of 140 declarations
Load more (115 remaining) 关于 GENELUX CORP GENELUX CORP 是一家在纳斯达克上市的公司，专注于开发创新的癌症治疗方法。该公司专门利用溶瘤病毒技术靶向并摧毁癌细胞。